86
Views
16
CrossRef citations to date
0
Altmetric
Original Article

O/W Lipid Emulsions for Parenteral Drug Delivery. III. Lipophilicity Necessary for Incorporation in Oil Particles Even After Intravenous Injection

&
Pages 119-127 | Received 09 Jul 1997, Accepted 28 Dec 1997, Published online: 26 Jun 2009

References

  • Collins-Gold L. C., Lyons R. T., Bartholow L. C. Parenteral emulsions for drug delivery. Adv. Drug Delivery Rev 1990; 5: 189–208
  • Davis S. S., Hadgraft J., Palin K. J. Medical and pharmaceutical applications of emulsions. Encyclopedia of Emulsion Technology, P. Becher. Marcel Dekker, New York 1985; 159–238
  • Davis S. S., Washington C., West P., Illum L., Liversidge G., Sternson L., Kirsh R. Lipid emulsions as drug delivery systems. Ann. N. Y. Acad. Sci 1987; 507: 75–88
  • Davis S. S., Ilium L., Moghimi S. M., Davies M. C., Porter C. J. H., Muir I. S., Brindley A., Christy N. M., Norman M. E., Williams P., Dunn S. E. Microspheres for targeting drugs to specific body sites. J. Controlled Release 1993; 24: 157–163
  • Hansch C., Leo A., Unger S. H., Kim K. H., Nikaitani D., Lien E. J. Aromatic substituent constants for structure-activity correlations. J. Med. Chem 1973; 16: 1207–1216
  • Heeg J. F., Hiser M. F., Satonin D. K., Rose J. Q. Pharmacokinetics of probucol in male rats. J. Pharm. Sci 1984; 73: 1758–1763
  • Igarashi R., Nakagawa M., Mizushima Y. Biological activity of several esterified PGE1 and the application of them to lipid microsphere (LM) preparations. Jpn. J. lnflamm 1988; 8: 243–246
  • Iriyama K. The metabolic distinctiveness of emulsified lipid particles in the bloodstream and its clinical implications. Surg. Today 1996; 26: 673–678
  • Kakutani T., Nishihara Y., Takahashi K., Hirano K. O/W lipid microemulsion for parenteral drug delivery. Proc. Int. Symp. Control Rel. Bioact. Mater 1991; 18: 359–360
  • Kurihara A., Shibayama Y., Yasuno A., Ikeda M., Hisaoka M. Lipid emulsions of palmitoylrhizoxin: effects of particle size on blood dispositions of emulsion lipid and incorporated compound in rats. Biopharm. Drug Dispos 1996a; 17: 343–353
  • Kurihara A., Shibayama Y., Mizota A., Yasuno A., Ikeda M., Hisaoka M. Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats. Biol. Pharm. Bull 1996b; 19: 252–258
  • Leo A., Jow P. Y. C., Silipo C., Hansch C. Calculation of hydrophobic constant (log P) from π and f constants. J. Med. Chem 1975; 18: 865–868
  • Mizushima Y. Lipo-prostaglandin preparations. Prostagl. Leukotr. Essent. Fatty Acids 1991; 42: 1–6
  • Mizushima Y., Shoji Y., Kato T., Fukushima M., Kurozumi S. Use of lipid microspheres as a drug carrier for antitumor drugs. J. Pharm. Pharmacol 1986; 38: 132–134
  • Mizushima Y., Igarashi R., Hoshi K., Sim A. K., Cleland M. E., Hayashi H., Goto J. Marked enhancement in antithrombotic activity of isocarbacyclin following its incorporation into lipid microspheres. Prostaglandins 1987; 33: 161–168
  • Moghimi S. M., Porter C. J. H., Muir I. S., Illum L., Davis S. S. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem. Biophys. Res. Commun 1991; 177: 861–866
  • Moghimi S. M., Davis S. S. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit. Rev. Ther. Drug Carrier Systems 1994; 11: 31–59
  • Oku N., Namba Y. Long-circulating liposomes. Crit. Rev. Ther. Drug Carrier Systems 1994; 11: 231–270
  • Patel K. R., Li M. P., Baldeschwieler J. D. Suppression of liver uptake of liposomes by dextran sulfate 500. Proc. Natl. Acad. Sci. USA 1983; 80: 6518–6522
  • Prankerd R. J., Stella V. J. The use of oil-in-water emulsions as a vehicle for parenteral drug administation. J. Parent. Sci. Technol 1990; 44: 139–149
  • Sakaeda (nee Kakutani) T., Takahashi K., Nishihara Y., Hirano K. O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II. Biol. Pharm. Bull 1994; 17: 1490–1495
  • Sakaeda (nee Kakutani) T., Hirano K. O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug. J. Drug Targeting 1995; 3: 221–230
  • Singh M., Ravin L. J. Parenteral emulsions as drug carrier systems. J. Parent. Sci. Technol 1986; 40: 34–41
  • Souhami R. L., Patel H. M., Ryman B. E. The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim. Biophys. Acta 1981; 674: 354–371
  • Takino T., Konishi K., Takakura Y., Hashida M. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol. Pharm. Bull 1994; 17: 121–125
  • Washington C., Evans K. Release rate measurements of model hydrophobic solutes from submicron triglyceride emulsions. J. Controlled Release 1995; 33: 383–390
  • Xu R. Particle size distribution analysis using light scattering. Liquid- and Surface-borne Particle Measurement Handbook, J. Z. Knapp, T. A. Barber, A. Lieberman. Marcel Dekker, New York 1996; 745–777
  • Yamaguchi T., Mizushima Y. Lipid microspheres for drug delivery from the pharmaceutical viewpoint. Crit. Rev. Ther. Drug Carrier Systems 1994; 11: 215–229
  • Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn 1981; 4: 879–885

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.